brilinta tablet
astrazeneca canada inc - ticagrelor - tablet - 60mg - ticagrelor 60mg - platelet aggregation inhibitors
blooms the chemist ticagrelor ticagrelor 90 mg tablet blister pack
arrotex pharmaceuticals pty ltd - ticagrelor, quantity: 90 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; iron oxide yellow; macrogol 400; purified talc; mannitol; magnesium stearate; titanium dioxide; hyprolose; hypromellose - blooms the chemist ticagrelor, in combination with aspirin, is indicated for the prevention of atherothrombotic events (cardiovascular death, myocardial infarction and stroke) in adult patients with acute coronary syndromes (unstable angina [ua], non st elevation myocardial infarction [nstemi] or st elevation myocardial infarction [stemi]) including patients managed medically, and those who are managed with percutaneous coronary intervention (pci) or coronary artery by-pass grafting (cabg).
kengrexal 50mg powder for concentrate for solution for injection infusion vials
chiesi ltd - cangrelor tetrasodium - powder for solution for injection - 50mg
brilinta 60 mg film-coated tablet
astrazeneca sdn. bhd. - ticagrelor -
brilique 90mg tablets
astrazeneca uk ltd - ticagrelor - tablet - 90mg
brilique 60mg tablets
astrazeneca uk ltd - ticagrelor - tablet - 60mg
brilique 90mg orodispersible tablets
astrazeneca uk ltd - ticagrelor - orodispersible tablet - 90mg
brilinta 90mg film-coated tablet
astrazeneca sdn. bhd. - ticagrelor -
brilinta tablets film-coated
astrazeneca ab gartunavagen - ticagrelor - tablets film-coated - 90mg
trixevas 90mg fc tablet
duopharma manufacturing (bangi) sdn bhd - ticagrelor -